Print Page   |   Contact Us   |   Sign In   |   Join Now
News & Press: General

CMS Approved RPA Kidney Quality Improvement Registry as 2017 QCDR

Thursday, May 18, 2017   (0 Comments)
Posted by: Lindsay Fox
Share |

CMS Approved RPA Kidney Quality Improvement Registry as 2017 QCDR


The RPA Kidney Quality Improvement Registry has once again been approved by CMS as a qualified clinical data registry (QCDR). As the only nephrology-specific QCDR, the RPA Registry gathers data from a variety of practices and geographies, allowing for meaningful benchmarking, comparison and insights at a national level. The RPA Registry may be used to report the three categories of MIPS for 2017: quality measures; advancing care information (ACI); and improvement activities (IA).

The RPA Registry includes 40 measures for 2017: 30 MIPS measures and 10 custom, clinically relevant measures RPA developed. This means a practice has the opportunity to choose quality measures that are developed by nephrologists for nephrologists that count toward participation in MIPS rather than being limited to the standard set of general quality measures published by CMS. In addition, reporting to the RPA Registry will satisfy the reporting to a clinical data registry measure of ACI and may entitle the provider to a 5 % bonus score. Reporting certain improvement activities through the RPA Registry will also earn a bonus, as will reporting quality measures via certified EHR technology. Please note, technical requirements must be met for these bonuses to apply.

To learn more about the RPA Registry, including the list of 2017 quality measures and interfaced EHRs, please visit the RPA website.

Membership Software Powered by YourMembership  ::  Legal